Target Name: MIR655
NCBI ID: G724025
Review Report on MIR655 Target / Biomarker Content of Review Report on MIR655 Target / Biomarker
MIR655
Other Name(s): MicroRNA 655 | microRNA 655 | MIRN655 | hsa-mir-655 | hsa-miR-655-3p | hsa-miR-655-5p | mir-655

MicroRNA-655: A Non-Coding RNA Molecule Regulating Various Biological Processes

MicroRNA (miRNA) 655 is a non-coding RNA molecule that plays a crucial role in various biological processes. It is made up of 204 amino acid residues and has a molecular weight of 23.4 kilobases (kb). MIR655 is a part of the miRNA family and is classified as a small molecule.

MIR655 is a key regulator of gene expression, and its levels have been shown to be regulated in various biological processes, including cell growth, apoptosis, and inflammation. MIR655 has been shown to play a role in the regulation of cell proliferation, and it has been shown to be involved in the development and progression of various diseases, including cancer.

One of the key functions of MIR655 is its ability to interact with other molecules, including microtubules of the mitotic spindle. MIR655 has been shown to physically interact with the protein kinesin-2, which is a key regulator of mitotic spindle formation and dynamics. This interaction between MIR655 and kinesin-2 has important implications for the regulation of cell division and the development of cancer.

In addition to its role in cell division, MIR655 is also involved in the regulation of apoptosis, which is the process by which cells die and are removed from the body. MIR655 has been shown to play a role in the regulation of apoptosis, and it has been shown to be involved in the protection of cells from apoptosis-induced stress.

MIR655 is also involved in the regulation of inflammation, and it has been shown to play a role in the regulation of immune responses. MIR655 has been shown to interact with the protein NF-kappa-B, which is a key regulator of inflammation. This interaction between MIR655 and NF-kappa-B has important implications for the regulation of immune responses and the development of inflammatory diseases.

MIR655 has also been shown to play a role in the regulation of cellular signaling pathways, including the regulation of cell adhesion and the regulation of cell-cell interactions. MIR655 has been shown to interact with the protein E-cadherin, which is a key regulator of cell-cell adhesion. This interaction between MIR655 and E-cadherin has important implications for the regulation of cell adhesion and the development of diseases such as cancer.

MIR655 is also involved in the regulation of cellular signaling pathways that are involved in the regulation of cell growth and the regulation of cell differentiation. MIR655 has been shown to interact with the protein T-cell factor, which is a key regulator of cell growth and differentiation. This interaction between MIR655 and T-cell factor has important implications for the regulation of cell growth and differentiation and the development of diseases such as cancer.

In conclusion, MIR655 is a non-coding RNA molecule that plays a crucial role in various biological processes. It is a key regulator of gene expression and is involved in the regulation of cell division, apoptosis, inflammation, and cellular signaling pathways. MIR655 has been shown to interact with other molecules, including kinesin-2, NF-kappa-B, E-cadherin, and T-cell factor. Its interactions with these molecules have important implications for the regulation of various biological processes and the development of diseases. Therefore, MIR655 is a potential drug target and a biomarker for various diseases, including cancer.

Protein Name: MicroRNA 655

The "MIR655 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR655 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794